Fulgent Genetics (FLGT) Operating Expenses (2015 - 2026)

Fulgent Genetics has disclosed Operating Expenses across 12 years of filings, most recently posting $61.8 million for Q2 2026.

• In Q2 2026, Operating Expenses rose 14.04% year-over-year to $61.8 million; the TTM figure through Jun 2026 stood at $237.5 million (up 22.37% YoY), while the FY2025 annual figure was $222.0 million, up 22.55% from the prior year.
• Operating Expenses came in at $61.8 million for Q2 2026 at Fulgent Genetics, up from $56.1 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $176.4 million in Q4 2023 to a low of $39.6 million in Q3 2023.
• Average Operating Expenses over 5 years is $56.1 million, with a median of $48.1 million recorded in 2024.
• Year-over-year, Operating Expenses soared 255.98% in 2023 and slumped 72.79% in 2024.
• Over 5 years, Operating Expenses stood at $49.5 million in 2022, then soared by 255.98% to $176.4 million in 2023, then slumped by 72.79% to $48.0 million in 2024, then surged by 43.42% to $68.8 million in 2025, then fell by 10.27% to $61.8 million in 2026.
• Per Business Quant data, the three most recent Operating Expenses figures were $61.8 million in Q2 2026, $56.1 million in Q1 2026, and $68.8 million in Q4 2025.